Analyzing GP Commitment Structures

Evaluates GP capital commitment levels, co-investment obligations, management company funding sources, and GP-LP alignment mechanisms across fund vehicles.

When To Use

• Reviewing a GP's proposed commitment level during fund formation or LP due diligence
• Assessing whether GP "skin in the game" is meaningful relative to fund size and GP net worth
• Analyzing the source of GP commitment capital (personal wealth vs. management fee recycling vs. credit facilities)
• Comparing GP commitment structures across funds in a program or peer group
• Evaluating co-invest obligation terms, GP catch-up provisions, or commitment-linked carry structures

Inputs To Gather

• LPA and side letter provisions — GP commitment amount, timing, form (cash vs. waived fees), and any commitment reduction triggers
• Fund size and target raise — total commitments to calculate GP percentage
• GP entity structure — management company, GP entity, carry vehicle, and any interposed holding entities
• Source-of-funds detail — personal capital, management fee offsets, GP credit lines, or third-party GP stake financing
• Co-investment terms — mandatory co-invest obligations, allocation priority, and co-invest vehicle economics
• Historical GP commitment data — prior fund commitment levels, actual funded amounts, and any commitment shortfalls
• Carry and incentive structure — how GP commitment interacts with carried interest waterfall, catch-up, and clawback

Workflow

1. Quantify the GP commitment

   • Identify the stated GP commitment amount and percentage of total fund size
   • Benchmark against market norms: typically 1–5% for large buyout/growth funds, often higher percentages for smaller or emerging managers [VERIFY against current market data]
   • Determine whether the commitment is a hard obligation or a target with flexibility provisions

2. Analyze source and quality of capital

   • Classify funding sources: personal/principal capital, management fee waivers (Section 707(a)(2)(A) considerations), recycled distributions, or GP credit facilities
   • Assess management fee waiver structures — confirm tax treatment and whether waiver creates genuine economic risk or is effectively a fee deferral [VERIFY tax treatment under current IRS guidance]
   • Flag any GP commitment funded by third-party GP stake investors (e.g., Dyal, Petershill) and evaluate whether this dilutes alignment
   • Note if GP uses a subscription credit facility to bridge commitment timing

3. Evaluate co-investment obligations and rights

   • Map mandatory co-invest obligations — when triggered, allocation methodology, and GP's right to decline
   • Assess whether co-invest capital is subject to same fee/carry terms or is fee-free/carry-free
   • Determine if co-invest commitments count toward the stated GP commitment percentage
   • Review co-invest allocation priority relative to LP co-invest rights

4. Assess alignment mechanisms

   • Analyze how GP commitment interacts with carried interest waterfall — does GP commit pari passu with LPs through the preferred return?
   • Review clawback obligations — is the GP commitment at risk in a clawback scenario, and is clawback joint and several or several only?
   • Evaluate commitment-linked carry adjustments — any provisions reducing carry if GP commitment falls below threshold
   • Check for "most favored nation" provisions that could alter GP commitment terms

5. Identify structural risks and red flags

   • GP commitment funded entirely through fee waivers with no personal capital at risk
   • Commitment percentage significantly below peer group without adequate justification
   • Credit facility-funded GP commitment with no personal recourse
   • Provisions allowing GP to reduce or withdraw commitment without LP consent
   • Mismatch between GP commitment in marketing materials versus LPA terms

6. Benchmark and contextualize

   • Compare against prior funds by the same GP (trend analysis)
   • Benchmark against peer group by strategy, vintage, and fund size
   • Consider GP net worth and overall economic exposure across fund family
   • Factor in management company economics (fee revenue, operating costs) for holistic alignment view

Output

Produce a structured GP Commitment Analysis Report containing:

• Commitment summary table — amount, percentage of fund, source breakdown, and timing schedule
• Source-of-capital analysis — classification of funding sources with risk-quality assessment (genuine risk capital vs. fee conversion)
• Co-investment obligation summary — trigger events, allocation mechanics, and economic terms
• Alignment scorecard — assessment of GP-LP alignment across commitment level, capital source, carry structure, and clawback provisions
• Peer benchmarking — comparison to market norms and prior fund commitments
• Risk flags — specific provisions or structures that weaken alignment, with cross-references to LPA sections
• Recommendations — suggested negotiation points or structural modifications to strengthen alignment

Quality Checks

• Confirm all GP commitment figures reconcile between the LPA, PPM, and any side letters
• Verify that management fee waiver calculations are consistent with the fee provisions in the LPA
• Cross-check co-invest obligation terms against the co-investment policy and any LP side letter carve-outs
• Ensure benchmarking data reflects comparable fund strategy, size, and vintage [VERIFY data source and recency]
• Validate that clawback and giveback provisions are accurately reflected in the alignment assessment
• Flag any jurisdiction-specific requirements affecting GP commitment minimums [VERIFY — some jurisdictions impose minimum GP contribution requirements]
• Confirm tax analysis of fee waiver structures reflects current guidance on Section 707(a)(2)(A) and related provisions [VERIFY]